Literature DB >> 10106480

Medicare, Medicaid and CLIA programs; revision of the laboratory regulations for the Medicare, Medicaid, and Clinical Laboratories Improvement Act of 1967 programs--HCFA. Final rule with comment period.

.   

Abstract

This rule revises regulations for laboratories regulated under the Medicare, Medicaid and Clinical Laboratories Improvement Act of 1967 (CLIA '67) programs. The revisions recodify the regulations for these programs into a new part 493 in order to simplify administration and unify the health and safety requirements for all programs as much as possible. We will now have a single set of regulations for the three programs, with an additional subpart for the licensure procedures unique to the CLIA program. We are revising the regulations to remove outdated, obsolete and redundant requirements, make provision for new technologies and place increased reliance on outcome measures of performance. We provide for new uniform proficiency testing standards. We have also added requirements for additional specialties, such as clinical cytogenetics. We also implement the now and self-implementing provisions of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88).

Mesh:

Year:  1990        PMID: 10106480

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  4 in total

1.  Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: results from a multicenter US study.

Authors:  Christopher L Owens; Dan Peterson; Aruna Kamineni; Diana S M Buist; Sheila Weinmann; Tyler R Ross; Andrew E Williams; Azadeh Stark; Kenneth F Adams; Terry S Field
Journal:  Cancer Cytopathol       Date:  2013-05-08       Impact factor: 5.284

2.  Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests.

Authors:  Christopher L Owens; Diana S M Buist; Daniel Peterson; Aruna Kamineni; Sheila Weinmann; Tyler Ross; Andrew E Williams; Azadeh Stark; Kenneth F Adams; Chyke A Doubeni; Terry S Field
Journal:  Cancer Cytopathol       Date:  2014-10-23       Impact factor: 5.284

3.  Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.

Authors:  Jason D Merker; Kelly Devereaux; A John Iafrate; Suzanne Kamel-Reid; Annette S Kim; Joel T Moncur; Stephen B Montgomery; Rakesh Nagarajan; Bryce P Portier; Mark J Routbort; Craig Smail; Lea F Surrey; Patricia Vasalos; Alexander J Lazar; Neal I Lindeman
Journal:  Arch Pathol Lab Med       Date:  2018-10-30       Impact factor: 5.534

4.  Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?

Authors:  Christophe E Depuydt; Marc Arbyn; Ina H Benoy; Johan Vandepitte; Annie J Vereecken; Johannes J Bogers
Journal:  J Cell Mol Med       Date:  2008-06-09       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.